Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 17 studies | 75% ± 22% | |
glutamatergic neuron | 11 studies | 67% ± 23% | |
oligodendrocyte precursor cell | 10 studies | 38% ± 19% | |
GABAergic neuron | 9 studies | 55% ± 25% | |
retinal cone cell | 8 studies | 74% ± 24% | |
astrocyte | 7 studies | 38% ± 19% | |
retinal ganglion cell | 6 studies | 53% ± 18% | |
neuron | 4 studies | 50% ± 15% | |
endothelial cell | 4 studies | 48% ± 17% | |
interneuron | 4 studies | 56% ± 29% | |
GABAergic interneuron | 3 studies | 58% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 53% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 4268.80 | 2593 / 2642 | 91% | 11.80 | 639 / 705 |
pancreas | 91% | 779.43 | 300 / 328 | 4% | 0.10 | 7 / 178 |
muscle | 43% | 243.21 | 345 / 803 | 0% | 0 | 0 / 0 |
skin | 1% | 4.76 | 20 / 1809 | 19% | 1.24 | 92 / 472 |
breast | 1% | 2.28 | 3 / 459 | 17% | 1.86 | 191 / 1118 |
peripheral blood | 12% | 107.99 | 113 / 929 | 0% | 0 | 0 / 0 |
thymus | 2% | 15.24 | 10 / 653 | 9% | 0.28 | 53 / 605 |
adipose | 9% | 42.74 | 111 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 6% | 21.37 | 15 / 258 | 3% | 0.06 | 7 / 230 |
lung | 4% | 14.93 | 21 / 578 | 5% | 0.40 | 56 / 1155 |
ovary | 4% | 15.68 | 8 / 180 | 0% | 0.00 | 1 / 430 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.10 | 2 / 45 |
esophagus | 2% | 9.69 | 22 / 1445 | 3% | 0.04 | 5 / 183 |
kidney | 0% | 0 | 0 / 89 | 4% | 0.14 | 38 / 901 |
uterus | 0% | 0 | 0 / 170 | 3% | 0.08 | 14 / 459 |
bladder | 0% | 0 | 0 / 21 | 3% | 0.16 | 13 / 504 |
prostate | 0% | 0 | 0 / 245 | 2% | 0.03 | 12 / 502 |
stomach | 0% | 0 | 0 / 359 | 2% | 0.08 | 6 / 286 |
eye | 0% | 0 | 0 / 0 | 1% | 0.05 | 1 / 80 |
blood vessel | 1% | 1.63 | 7 / 1335 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.02 | 2 / 406 |
intestine | 0% | 0.31 | 1 / 966 | 0% | 0.01 | 2 / 527 |
heart | 0% | 0.68 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016560 | Biological process | protein import into peroxisome matrix, docking |
GO_0043949 | Biological process | regulation of cAMP-mediated signaling |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0005829 | Cellular component | cytosol |
GO_0043235 | Cellular component | receptor complex |
GO_0000268 | Molecular function | peroxisome targeting sequence binding |
GO_0005052 | Molecular function | peroxisome matrix targeting signal-1 binding |
GO_0031267 | Molecular function | small GTPase binding |
Gene name | PEX5L |
Protein name | Peroxisomal biogenesis factor 5 like PEX5-related protein (PEX2-related protein) (PEX5-like protein) (Peroxin-5-related protein) (Peroxisome biogenesis factor 5-like) (Tetratricopeptide repeat-containing Rab8b-interacting protein) (Pex5Rp) (TRIP8b) |
Synonyms | PXR2 PEX5R |
Description | FUNCTION: Accessory subunit of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, regulating their cell-surface expression and cyclic nucleotide dependence. . |
Accessions | C9JZE2 ENST00000496721.5 ENST00000472994.5 [Q8IYB4-4] ENST00000464614.5 [Q8IYB4-7] ENST00000469198.5 ENST00000485199.5 [Q8IYB4-3] ENST00000467460.6 [Q8IYB4-1] C9JB85 ENST00000476138.5 [Q8IYB4-5] Q8IYB4 ENST00000463761.1 C9JUZ5 C9IZ09 ENST00000263962.12 [Q8IYB4-2] ENST00000491640.5 ENST00000468741.5 [Q8IYB4-8] ENST00000465751.5 [Q8IYB4-6] ENST00000392649.7 [Q8IYB4-7] |